{
  "id": 6500471,
  "title": "iShares' IYH or Invesco's PBE: Which Healthcare ETF Is the Better Long-Term Buy?",
  "url": "https://urgent.news/2026/09/09/ishares-iyh-or-invescos-pbe-which-healthcare-etf-is-the-better-long",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-09T23:00:18.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/coverage/etfs/2026/09/09/ishares-iyh-or-invesco-s-pbe-which-healthcare-etf-is-the-better-long-term-buy/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": null,
  "summary": "Broad diversification and lower costs favor iShares, but Invesco's concentrated biotech bet delivered 47% returns in one year—at the cost of steeper drawdowns.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "iShares' IYH or Invesco's PBE: Which Healthcare ETF Is the Better Long-Term Buy?",
        "url": "https://urgent.news/2026/09/09/ishares-iyh-or-invescos-pbe-which-healthcare-etf-is-the-better-long-6501687",
        "published": "2026-09-09T23:20:18.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}